Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: Clinical Approaches and Review of Current Available Evidence

Author： Prasad Suyash  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.10, Iss.1, 2008-01, pp. : 39-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P.   Keating Gillian M.  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

By Mazzone Luigi  

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 503-509

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis

By Cheng Jackie   Chen Ronald   Ko John   Ng Emil  

Psychopharmacology, Vol. 194, Iss. 2, 2007-10 ,pp. : 197-209

Springer Publishing Company

Access to resources Recommend Favorite